Advanced search

Instruments

Name		Stock exchange	Average volume	Price	Type
TAKEDA PHARMACEUTICAL COMPANY LIMITED	TAK	Nyse +5 Other	1,475,479	13.25 USD	Stock
TAKEDA PHARMACEUTICAL COMPANY LIMITED	TAK N	Mexican S.E.	4,851	240.5 MXN
TAKEDA PHARMACEUTICAL COMPANY LIMITED	TKDA	Deutsche Boerse AG	0	12.6 EUR
TAKEDA PHARMACEUTICAL COMPANY LIMITED	TKDA	Börse Stuttgart	-	12 EUR
TAKEDA PHARMACEUTICAL COMPANY LIMITED	TKDA	BOERSE MUENCHEN	27	12.3 EUR
TAKEDA PHARMACEUTICAL COMPANY LIMITED	0A87	London S.E.	291	13.1 USD
TAKEDA PHARMACEUTICAL COMPANY LIMITED	TAKP34	Sao Paulo	18	66.46 BRL	Stock
TAKEDA PHARMACEUTICAL COMPANY LIMITED	4502	Japan Exchange +8 Other	4,118,750	4,129 JPY	Stock
TAKEDA PHARMACEUTICAL COMPANY LIMITED	TKD	Deutsche Boerse AG	229	24.38 EUR
TAKEDA PHARMACEUTICAL COMPANY LIMITED	0RN3	London S.E.	0	37.59 EUR
TAKEDA PHARMACEUTICAL COMPANY LIMITED	TKD	Börse Stuttgart	-	24.35 EUR
TAKEDA PHARMACEUTICAL COMPANY LIMITED	TKD	BOERSE MUENCHEN	156	24.6 EUR
TAKEDA PHARMACEUTICAL COMPANY LIMITED	TKPHF	OTC Markets	12,864	26.83 USD
TAKEDA PHARMACEUTICAL COMPANY LIMITED	TKD	Wiener Boerse	4	24.34 EUR
TAKEDA PHARMACEUTICAL COMPANY LIMITED	4502	Fukuoka Stock Exchange	0	4,080 JPY
TAKEDA PHARMACEUTICAL COMPANY LIMITED	4502	Sapporo S.E.	0	4,300 JPY
TAKEDA MACHINERY CO., LTD.	6150	Japan Exchange	4,125	4,190 JPY	Stock
TAKEDA IP HOLDINGS CO.,LTD.	7875	Japan Exchange	5,508	851 JPY	Stock
TAKEDA P 5.0/NOV28		Deutsche Boerse AG	-	98.77 %	Obligation
MINI SHORT - TAKEDA PHARMACEUTICAL ADR	MINI S TAK AVA	Nasdaq Stockholm	-	- SEK	Certificat
MINI LONG - TAKEDA PHARMACEUTICAL ADR	MINI L TAK AVA	Nasdaq Stockholm	-	- SEK	Certificat
PROTECT MULTI AKTIENANLEIHE - TAKEDA PHARMACEUTICAL/PANASONIC HOLDINGS		Boerse Frankfurt Warrants	-	96.59 JPY	Certificat
PROTECT MULTI AKTIENANLEIHE - TAKEDA PHARMACEUTICAL/PANASONIC HOLDINGS		Deutsche Boerse AG	-	96.59 JPY	Certificat

See all

News (15)

Takeda Pharmaceutical : ADZYNMA (ADAMTS13, recombinant-krhn) Approved by U.S. FDA as the First and Only Recombinant ADAMTS13 Enzyme Replacement Therapy for the Treatment of Congenital Thrombotic Thrombocytopenic Purpura (cTTP) - Form 6-K	13/11	PU
TAKEDA PHARMACEUTICAL : Form 6-K	01/23/01	PU
Takeda Pharmaceutical : Annual Securities Report	28/23/28	PU
Takeda Pharmaceutical : Annual Security Report (page 83-112)	28/23/28	PU
Sumitomo Mitsui Financial : Organizational and Personnel Changes	16/23/16	PU
Takeda Pharmaceutical : Quarterly Securities Report for the 3rd Quarter	07/23/07	PU
Takeda Pharmaceutical : Quarterly Securities Report for the 2nd Quarter	04/22/04	PU
Takeda Pharmaceutical : Quarterly Securities Report for the 1st Quarter	04/22/04	PU
Takeda Pharmaceutical : Current Report by Foreign Issuer (Form 6-K)	31/22/31	PU
Takeda Pharmaceutical : Current Report by Foreign Issuer (Form 6-K)	31/22/31	PU
Terumo : to Implement New Executive Officers' Management System	09/22/09	PU
General Announcement::Share Repurchase Report (From November 1, 2021 to November 30, 2021)	14/21/14	PU
Quarterly Securities Report(The second quarter of 145th Business Term) for The Six-month Period and Three-month Quarter Ended September 30, 2021	05/21/05	PU
Takeda Pharmaceutical : Norimasa Takeda Chief Accounting Officer and Corporate Controller (Form 6-K)	29/21/29	PU
(Research Paper) Emerging Economies' Vulnerability to Changes in Capital Flows: The Role of Global and Local Factors	26/21/26	PU

Companies (7)

TAKEDA PHARMACEUTICAL COMPANY LIMITED 41 558 M $

Takeda Pharmaceutical Company Limited specializes in the development, manufacturing and marketing of pharmaceutical products especially for metabolic and cardiovascular diseases, cancers and central nervous systems troubles. The activity is organized arou ...

TAKEDA PHARMACEUTICAL COMPANY LIMITED 41 558 M $

AFFYMAX, INC. 28 117 $

Affymax, Inc. is a biopharmaceutical company. The Companyâs product OMONTYS (peginesatide) is for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent ...

TAKEDA IP HOLDINGS CO.,LTD. 45 M $

Takeda iP Holdings Co Ltd, formerly Takeda Printing Co Ltd, is mainly engaged in the printing business. The Company operates in two business segments. The Printing segment has two businesses. The printing business is engaged in planning and production of ...

TAKEDA MACHINERY CO., LTD. 25 M $

TAKEDA MACHINERY CO., LTD. is a Japan-based company mainly engaged in the manufacture and sale of shaped steel processing machines and circular saw machines for the processing of steel frames, steel materials, sheet metals and others. The Machine Tools Re ...

DRI HEALTHCARE TRUST 628 M $

DRI Healthcare Trust is a Canada-based company, which is engaged in providing financing to advance innovation in the life sciences industry. The Company is involved in pharmaceutical royalty monetization and provides capital to inventors, academic institu ...

Insiders

Norimasa Takeda

Mr. Norimasa Takeda is a Chief Accounting Officer & Corporate Controller at Takeda Pharmaceutical Co., Ltd.

Norimasa Wada

Norimasa Wada formerly worked at WADAKOHSAN CORP., as Chairman from 2008 to 2022.
Mr. Wada received his graduate degree in 1962 from Faculty of Law, Keio University and undergraduate degree in 1957 from Hyogo Technical High School.

Norimasa Shinya is currently working as a Senior Analyst at Mizuho Securities Co., Ltd.
(Broker).

Norimasa Togami

Norimasa Tamura

Norimasa Tamura has a current job as a Non-Executive Director at The Chugoku Electric Power Co., Inc.

Norimasa Tomono

No results for this search